SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wollheim FA. Ankylosing spondylitis. In: KelleyWN, HarrisED, RuddyS, SledgeCB, editors. Textbook of rheumatology. 4th ed. Philadelphia: WB Saunders; 1993. p. 94360.
  • 2
    Gran JT, Skomsvoll JF. The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 1997; 36: 76671.
  • 3
    Maksymowych WP, Adlam N, Lind D, Russell AS. Polymorphism of the LMP2 gene and disease phenotype in ankylosing spondylitis: no association with disease severity. Clin Rheumatol 1997; 16: 4615.
  • 4
    Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 72735.
  • 5
    Scott DL, van Riel PL, van der Heijde D, Benke AS. Assessing disease activity in rheumatoid arthritis. In: The EULAR handbook of standard methods. London: The EULAR Standing Committee for International Clinical Studies; 1993.
  • 6
    Van der Heijde D, Bellamy N, Calin A, Dougados M, Khan MA, van der Linden S. Preliminary core sets for endpoints in ankylosing spondylitis. J Rheumatol 1997; 24: 22259.
  • 7
    Van der Heijde D, Calin A, Dougados M, Khan MA, van der Linden S, Bellamy N. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis: progress report of the ASAS group. J Rheumatol 1999; 26: 9514.
  • 8
    Van der Heijde D, van der Linden S, Dougados M, Bellamy N, Russell A, Edmonds J. Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments. J Rheumatol 1999; 26: 10035.
  • 9
    Felson DT, Anderson JJ, Meenan RF. Time for changes in the design, analysis, and reporting of rheumatoid arthritis clinical trials. Arthritis Rheum 1990; 33: 1409.
  • 10
    Van Riel PLCM, van de Putte LBA. DC-ART: what proportion of response constitutes a positive response? J Rheumatol 1994; 21 Suppl 41: 546.
  • 11
    Bellamy N. Weighting and aggregation. In: BellamyN, editor. Musculoskeletal clinical metrology. Boston: Kluwer Academic Publishers; 1993. p. 4552.
  • 12
    The Cochrane Collaboration web site. URL: www.update-softare.com/ccweb/default.htw. Accessed April 24, 2001.
  • 13
    Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. Br Med J 1995; 310: 4524.
  • 14
    Bland M, Altman D. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 30710.
  • 15
    Bland M, Altman DG. Comparing two methods of clinical measurement: a personal history. Int J Epidemiol 1995; 24 Suppl 1: S714.
  • 16
    Dougados M. Response criteria in OA trials. Ann Rheum Dis 2000; 59: 11.
  • 17
    Hajjaj-Hassouni N, Maetzel A, Dougados M, Amor B. Comparaison des malades examinés pour spondylarthrotpathie en France et au Maroc. Rev Rhum (Ed Fr) 1993; 60: 4205.
  • 18
    Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 3618.
  • 19
    Guidelines for the clinical evaluation of anti-inflammatory and anti-rheumatic drugs (adults and children). Washington (DC): US Department of Health and Human Services, Public Health Service, Food and Drug Administration; 1988. p. 3840.
  • 20
    Dougados M, Gueguen A, Nakache JP, Nguyen M, Amor B. Evaluation of a functional index for patients with ankylosing spondylitis. J Rheumatol 1990; 17: 12545.
  • 21
    Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21: 22815.
  • 22
    Jones SD, Steiner A, Garrett SL, Calin A. The Bath ankylosing spondylitis patient global score (BAS-G). Br J Rheumatol 1996; 35: 6671.
  • 23
    Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 228691.
  • 24
    Mander M, Simpson JM, McLellan A, Walker D, Goodacre JA, Dick WC. Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 1987; 46: 197202.
  • 25
    Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86: 4208.
  • 26
    Claudepierre P, Sibilia J, Goupille P, Flipo R-M, Wendling D, Eurly F, et al. Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondylarthropathy. J Rheumatol 1997; 24: 19549.
  • 27
    Creemers MCW, Van 't Hof MA, Franssen MJAM, van de Putte LBA, Gribnau FWJ, van Riel PLCM. Disease activity in ankylosing spondylitis: selection of a core set of variables and a first step in the development of a disease activity score. Br J Rheumatol 1996; 35: 86773.
  • 28
    Cronstedt H, Waldner A, Stenström CH. The Swedish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity. Scand J Rheumatol 1999; 28 Suppl 111: 19.
  • 29
    Dougados M, Gueguen A, Nakache J-P, Nguyen M, Mery C, Amor B. Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol 1988; 15: 3027.
  • 30
    Roberts WN, Liang MH, Pallozzi LM, Daltroy LH. Effects of warming up on reliability of anthropometric techniques in ankylosing spondylitis. Arthritis Rheum 1988; 31: 54952.
  • 31
    Viitanen JV, Kokko M-L, Lehtinen K, Suni J, Kautiainen H. Correlation between mobility restrictions and radiologic changes in ankylosing spondylitis. Spine 1995; 20: 4926.
  • 32
    Viitanen JV, Kokko M-L, Heikkilä S, Kautiainen H. Neck mobility assessment in ankylosing spondylitis: a clinical study of nine measurements including new tape methods for cervical rotation and lateral flexion. Br J Rheumatol 1998; 37: 37781.
  • 33
    Viitanen JV, Heikkilä S, Kokko M-L, Kautiainen H. Clinical assessment of spinal mobility measurements in ankylosing spondylitis: a compact set for follow-up and trials? Clin Rheumatol 2000; 19: 1317.
  • 34
    Viitanen JV, Kokko M-L, Heikkilä S, Kautiainen H. Assessment of thoracolumbar rotation in ankylosing spondylitis: a simple tape method. Clin Rheumatol 1999; 18: 1527.
  • 35
    Lassere M, Boers M, van der Heijde D, Boonen A, Edmonds J, Saudan A, et al. Smallest detectable difference in radiological progression. J Rheumatol 1999; 26: 7319.
  • 36
    Pile KD, Laurent MR, Salmond CE, Best MJ, Pyle EA, Moloney RO. Clinical assessment of ankylosing spondylitis: a study of observer variation in spinal measurements. Br J Rheumatol 1991; 30: 2934.